Results for CNS Tumors

Share:
1 - 10 of 10
Angela N. Viaene, MD, PhD
Angela N. Viaene

Dr. Viaene's research interests include thalamocortical projections, CNS tumors, neurogenetic disorders, and hypoxic/ischemic brain injury.

E-mail:
viaenea [at] chop.edu
Thomas De Raedt, PhD
Thomas De Raedt

Dr. De Raedt researches pediatric high grade glioma development and aims to understand the involvement of crucial pathways. He investigates pathway interaction, and explores ways to develop therapies through analyzing human tumors, performing cellular studies, and developing accurate mouse models. This allows Dr. De Raedt and his team to perform novel pre-clinical studies that can lead to clinical trials.

E-mail:
deraedtt [at] chop.edu
Shih-Shan Lang Chen, MD
Shih-Shan Lang Chen

Dr. Chen's research focuses on traumatic brain injury (TBI), multimodal neuromonitoring, and neurovascular disorders. She is interested in non-invasive forms of neuromonitoring thus leading to research efforts identifying reliable non-invasive methods for detecting intracranial hypertension in multiple disease processes including TBI and craniosynostosis.

E-mail:
chens4 [at] chop.edu
Benjamin C. Kennedy, MD
Benjamin C. Kennedy

Dr. Kennedy's current research focuses on epilepsy genetics and epilepsy surgery, including stereo-EEG, hemispherotomy, corpus callosotomy, and vagal nerve stimulation.

E-mail:
kennedybc [at] chop.edu

In the News: Aplastic Anemia, Boricua Mutation, Oligodendroglioma, cWGS Infants

Published on
Oct 1, 2021
in Cornerstone Blog
In the News
This week’s roundup features new partnerships, novel findings, and exciting approaches to diagnosing rare conditions.

CHOP Cell and Gene Therapy Experts Elected to National Academy of Medicine

Published on
Oct 21, 2019
in Cornerstone Blog
Stephen A. Grupp and Beverly Davidson
Join us in congratulating cell and gene therapy experts Beverly Davidson, PhD, and Stephan Grupp, MD, PhD, newly elected to the National Academy of Medicine.

Life After Childhood Cancer: Q&A With Matthew Hocking, PhD

Published on
Apr 24, 2018
in Cornerstone Blog
Matthew Hocking, PhD
Researchers in the Hocking Research Program study how to improve the quality of life for childhood cancer survivors.

Head Start 4 Protocol for Children with Medulloblastoma and CNS Embryronal Tumors

Head Start 4 Protocol for Children with Medulloblastoma and CNS Embryronal Tumors

Children (less than 10 years of age) are eligible if they have been diagnosed with either a medulloblastoma tumor or CNS embryonal tumors of the brain or spinal cord.

Selpercatinib in Solid or CNS tumors with RET-Alterations

The purpose of this study is to test the safety and efficacy of the investigational drug called Selpercatinib in children whose cancers have a specific genetic change (RET-fusion or RET-mutation).

De Raedt Laboratory

De Raedt Laboratory

Research in the De Raedt Lab centers on pediatric high-grade glioma development and aims to understand the involvement of crucial pathways that drive these pediatric brain tumors.

1 - 10 of 10